BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22584361)

  • 1. Sunitinib-induced autoimmune thyroiditis in a patient with metastatic renal cell carcinoma: a case report.
    Babacan T; Sevinc A; Akarsu E; Balakan O
    Chemotherapy; 2012; 58(2):142-5. PubMed ID: 22584361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
    Pani F; Atzori F; Baghino G; Boi F; Tanca L; Ionta MT; Mariotti S
    Thyroid; 2015 Nov; 25(11):1255-61. PubMed ID: 26414109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.
    Alexandrescu DT; Popoveniuc G; Farzanmehr H; Dasanu CA; Dawson N; Wartofsky L
    Thyroid; 2008 Jul; 18(7):809-12. PubMed ID: 18631016
    [No Abstract]   [Full Text] [Related]  

  • 4. Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression.
    Kappers MH; van Esch JH; Smedts FM; de Krijger RR; Eechoute K; Mathijssen RH; Sleijfer S; Leijten F; Danser AH; van den Meiracker AH; Visser TJ
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3087-94. PubMed ID: 21816788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotoxicosis during sunitinib treatment for renal cell carcinoma.
    Grossmann M; Premaratne E; Desai J; Davis ID
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):669-72. PubMed ID: 18394019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma.
    Sato S; Muraishi K; Tani J; Sasaki Y; Tokubuchi I; Tajiri Y; Yamada K; Suekane S; Miyajima J; Matsuoka K; Hiromatsu Y
    Endocr J; 2010; 57(10):873-80. PubMed ID: 20733268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study.
    Baldazzi V; Tassi R; Lapini A; Santomaggio C; Carini M; Mazzanti R
    Urol Oncol; 2012 Sep; 30(5):704-10. PubMed ID: 20884255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: comparison with thyroid function.
    Kitajima K; Takahashi S; Maeda T; Yoshikawa T; Ohno Y; Fujii M; Miyake H; Fujisawa M; Sugimura K
    Eur J Radiol; 2012 Sep; 81(9):2060-5. PubMed ID: 21724350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?
    Tassi R; Baldazzi V; Lapini A; Carini M; Mazzanti R
    Clin Genitourin Cancer; 2015 Apr; 13(2):e101-5. PubMed ID: 25450040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
    Rini BI; Tamaskar I; Shaheen P; Salas R; Garcia J; Wood L; Reddy S; Dreicer R; Bukowski RM
    J Natl Cancer Inst; 2007 Jan; 99(1):81-3. PubMed ID: 17202116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.
    Wolter P; Stefan C; Decallonne B; Dumez H; Bex M; Carmeliet P; Schöffski P
    Br J Cancer; 2008 Aug; 99(3):448-54. PubMed ID: 18665181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
    Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
    Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake.
    Mannavola D; Coco P; Vannucchi G; Bertuelli R; Carletto M; Casali PG; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3531-4. PubMed ID: 17595247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma.
    Pilanc KN; Elbüken F; Ordu Ç; Köksal G; Tekelioğlu MH; Okutur K; Göksel S; Köksal Ü; Akçal T; Tecimer C
    Am J Ther; 2016; 23(2):e583-7. PubMed ID: 24901901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction?
    Rogiers A; Wolter P; Op de Beeck K; Thijs M; Decallonne B; Schöffski P
    Thyroid; 2010 Mar; 20(3):317-22. PubMed ID: 20144039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma.
    Yoong J; Chong G; Hamilton K
    Med Oncol; 2011 Dec; 28 Suppl 1():S395-7. PubMed ID: 21057897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer.
    Del Fabbro E; Dev R; Cabanillas ME; Busaidy NL; Rodriguez EC; Bruera E
    J Chemother; 2012 Aug; 24(4):221-5. PubMed ID: 23040687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleural and pericardial effusions combined with ascites in a patient with severe sunitinib-induced hypothyroidism.
    Kust D; Kruljac I; Peternac AŠ; Ostojić J; Prpić M; Čaržavec D; Gaćina P
    Acta Clin Belg; 2016 Jun; 71(3):175-7. PubMed ID: 26319226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib induces hypothyroidism with a markedly reduced vascularity.
    Makita N; Miyakawa M; Fujita T; Iiri T
    Thyroid; 2010 Mar; 20(3):323-6. PubMed ID: 20187785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib-induced thyrotoxicosis followed by persistent hypothyroidism with shrinkage of thyroid volume.
    Sakurai K; Fukazawa H; Arihara Z; Yoshida K
    Tohoku J Exp Med; 2010 Sep; 222(1):39-44. PubMed ID: 20814176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.